We are live on ! Find out more
FA

Forefront Analytics Portfolio holdings

AUM $92M
1-Year Est. Return 25.18%
This Fund
S&P 500
This Quarter Est. Return
+14.39%
1 Year Est. Return
+25.18%
3 Year Est. Return
+50.89%
5 Year Est. Return
+36.12%
10 Year Est. Return
–
AUM
$92M
AUM Growth
-$17.9M
Cap. Flow
-$31.5M
Cap. Flow %
-34.18%
Top 10 Hldgs %
82.69%
Holding
39
New
–
Increased
19
Reduced
15
Closed
2

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.09M
2
DHR icon
Danaher
DHR
+$137K
3
PFE icon
Pfizer
PFE
+$134K
4
INCY icon
Incyte
INCY
+$85.1K
5
HDV
iShares Core High Dividend ETF
HDV
+$63.1K

Top Sells

Rank Stock Value
1
ESGD icon
iShares ESG Aware MSCI EAFE ETF
ESGD
+$15.3M
2
ESGE icon
iShares ESG Aware MSCI EM ETF
ESGE
+$9.25M
3
ESGG icon
Northern Trust STOXX Global ESG Select ETF
ESGG
+$5.02M
4
NULV icon
Nuveen ESG Large-Cap Value ETF
NULV
+$2.71M
5
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$236K

Sector Composition

Rank Sector Weight
1 Miscellaneous 87.11%
2 Healthcare 5.43%
3 Technology 4.25%
4 Financials 2.11%
5 Industrials 0.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OTF
26
Blue Owl Technology Finance Corp
OTF
$5.26B
$307K 0.33%
29,654
– –
LEGN icon
27
Legend Biotech
LEGN
$4.21B
$305K 0.33%
10,568
-5,091
-33% -$137K
PM icon
28
Philip Morris
PM
$288B
$265K 0.29%
1,463
+13
+0.9% +$2.25K
REGN icon
29
Regeneron Pharmaceuticals
REGN
$86.2B
$259K 0.28%
415
-45
-10% -$30.6K
SCHD icon
30
Schwab US Dividend Equity ETF
SCHD
$112B
$243K 0.26%
7,676
-7,443
-49% -$236K
VTV icon
31
Vanguard Morningstar Value ETF
VTV
$194B
$236K 0.26%
1,084
-233
-18% -$48.7K
ZURA icon
32
Zura Bio
ZURA
$572M
$159K 0.17%
26,968
+12,067
+81% +$57.5K
GERN icon
33
Geron
GERN
$957M
$114K 0.12%
88,779
+33,654
+61% +$47.4K
CTMX icon
34
CytomX Therapeutics
CTMX
$776M
$93.9K 0.1%
25,033
+12,557
+101% +$47.9K
BCYC
35
Bicycle Therapeutics
BCYC
$298M
$92.5K 0.1%
21,822
+7,428
+52% +$34.1K
NKTX icon
36
Nkarta
NKTX
$201M
$81.9K 0.09%
28,955
-14,880
-34% -$41.9K
ANNX icon
37
Annexon
ANNX
$921M
$81.3K 0.09%
14,240
– –
DFSV
38
Dimensional US Small Cap Value ETF
DFSV
$8.44B
– –
-6,341
Closed -$222K
MREO
39
Mereo BioPharma
MREO
$41.5M
– –
-127,778
Closed -$42.2K
1
2

Similar funds

VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
PBCM
Point Break Capital Management Miami, Florida $91.7M AUM
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $92.3M AUM 0.12% 1-Year Est. Return
DCA
DB&C Advisors Holland, Michigan $92.4M AUM
SWP
Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return
SAM
Sunstone Asset Management New York $92.4M AUM

Forefront Analytics's Q2 2026 Portfolio in Review

As of Q2 2026, Forefront Analytics held 39 positions worth $92M, down 16% from $110M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Forefront Analytics withdrew a net $31.5M in Q2 2026, closing 2 positions and reducing 15 holdings. Its most notable exit was Dimensional US Small Cap Value ETF, an estimated $222K position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, down from 91% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Forefront Analytics added an estimated $1.09M to NVIDIA.

  • Forefront Analytics added most to NVIDIA in Q2 2026, an estimated $1.09M increase.
  • Forefront Analytics's biggest Q2 2026 reduction was iShares ESG Aware MSCI EAFE ETF, cutting an estimated $15.3M.
  • Forefront Analytics fully exited Dimensional US Small Cap Value ETF in Q2 2026, selling an estimated $222K.
  • Forefront Analytics's ten largest holdings make up 83% of its $92M portfolio in Q2 2026.
  • Forefront Analytics opened 0 new positions and closed 2 in Q2 2026.
  • Forefront Analytics's portfolio value fell 16% quarter-over-quarter to $92M.

Based on Forefront Analytics's 13F filing for Q2 2026, filed 13 Aug 2026.